Cholesterol depletion enhances adrenergic signaling in cardiac myocytes.
暂无分享,去创建一个
[1] S. Shrivastava,et al. Chronic cholesterol depletion using statin impairs the function and dynamics of human serotonin(1A) receptors. , 2010, Biochemistry.
[2] Kai Simons,et al. Lipid Rafts As a Membrane-Organizing Principle , 2010, Science.
[3] A. Chattopadhyay,et al. Membrane cholesterol depletion from live cells enhances the function of human serotonin(1A) receptors. , 2009, Biochemical and biophysical research communications.
[4] E. Ponimaskin,et al. G protein--mediated signaling: same receptor, multiple effectors. , 2009, Current molecular pharmacology.
[5] Beilei Lei,et al. Lipid rafts constrain basal alpha(1A)-adrenergic receptor signaling by maintaining receptor in an inactive conformation. , 2009, Cellular signalling.
[6] G. Dorn,et al. Mechanisms of Pharmacogenomic Effects of Genetic Variation within the Cardiac Adrenergic Network in Heart Failure , 2009, Molecular Pharmacology.
[7] A. Chattopadhyay,et al. The function of G-protein coupled receptors and membrane cholesterol: specific or general interaction? , 2009, Glycoconjugate Journal.
[8] J. Floras. Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. , 2009, Journal of the American College of Cardiology.
[9] L. Delbridge,et al. Angiotensin II: a regulator of cardiomyocyte function and survival. , 2009, Frontiers in bioscience.
[10] S. Rasmussen,et al. The structure and function of G-protein-coupled receptors , 2009, Nature.
[11] C. Tautermann,et al. G-protein-coupled receptor-focused drug discovery using a target class platform approach. , 2009, Drug discovery today.
[12] A. Chattopadhyay,et al. Are specific nonannular cholesterol binding sites present in G-protein coupled receptors? , 2009, Biochimica et biophysica acta.
[13] Youngil Lee,et al. Role of apoptosis in cardiovascular disease , 2009, Apoptosis.
[14] Y. Percherancier,et al. Cholesterol-dependent Separation of the β2-Adrenergic Receptor from Its Partners Determines Signaling Efficacy , 2008, Journal of Biological Chemistry.
[15] C. Taira,et al. Therapeutic implications of beta-adrenergic receptor pharmacodynamic properties. , 2008, Current clinical pharmacology.
[16] R. Stevens,et al. A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. , 2008, Structure.
[17] Yi-Sook Jung,et al. Norepinephrine- and Epinephrine-induced Distinct β2-Adrenoceptor Signaling Is Dictated by GRK2 Phosphorylation in Cardiomyocytes* , 2008, Journal of Biological Chemistry.
[18] R. Stevens,et al. High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.
[19] Sudhiranjan Gupta,et al. Cardiac hypertrophy: mechanisms and therapeutic opportunities. , 2007, Antioxidants & redox signaling.
[20] Raphael Zidovetzki,et al. Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies. , 2007, Biochimica et biophysica acta.
[21] A. Chattopadhyay,et al. Cholesterol depletion induces dynamic confinement of the G-protein coupled serotonin(1A) receptor in the plasma membrane of living cells. , 2007, Biochimica et biophysica acta.
[22] A. Chattopadhyay,et al. Cholesterol: a potential therapeutic target in Leishmania infection? , 2007, Trends in parasitology.
[23] E. Gulbins,et al. Membrane rafts in host-pathogen interactions. , 2006, Biochimica et biophysica acta.
[24] A. Chattopadhyay,et al. Membrane cholesterol in the function and organization of G-protein coupled receptors. , 2006, Sub-cellular biochemistry.
[25] S. Goswami,et al. An assessment of the role of reactive oxygen species and redox signaling in norepinephrine-induced apoptosis and hypertrophy of H9c2 cardiac myoblasts. , 2006, Antioxidants & redox signaling.
[26] R. Horuk,et al. I want a new drug: G-protein-coupled receptors in drug development. , 2006, Drug discovery today.
[27] Yang Zhang,et al. Structure Modeling of All Identified G Protein–Coupled Receptors in the Human Genome , 2006, PLoS Comput. Biol..
[28] B. Kobilka,et al. Using synthetic lipids to stabilize purified beta2 adrenoceptor in detergent micelles. , 2005, Analytical biochemistry.
[29] Amitabha Chattopadhyay,et al. The Serotonin1A A Receptor: A Representative Member of the Serotonin Receptor Family , 2005, Cellular and Molecular Neurobiology.
[30] R. Liao,et al. &agr;-Adrenergic Receptor–Stimulated Hypertrophy in Adult Rat Ventricular Myocytes Is Mediated via Thioredoxin-1–Sensitive Oxidative Modification of Thiols on Ras , 2005, Circulation.
[31] M. Zuckermann,et al. What's so special about cholesterol? , 2004, Lipids.
[32] M. Bacaner,et al. Prevention of Ventricular Fibrillation, Acute Myocardial Infarction (Myocardial Necrosis), Heart Failure, and Mortality by Bretylium: Is Ischemic Heart Disease Primarily Adrenergic Cardiovascular Disease? , 2004, American journal of therapeutics.
[33] A. Loonen,et al. An Extracellular Signal-Regulated Kinase 1- and 2-Dependent Program of Chromatin Trafficking of c-Fos and Fra-1 Is Required for Cyclin D1 Expression during Cell Cycle Reentry , 2004, Molecular and Cellular Biology.
[34] A. Chattopadhyay,et al. Cholesterol modulates ligand binding and G-protein coupling to serotonin(1A) receptors from bovine hippocampus. , 2004, Biochimica et biophysica acta.
[35] O. Civelli,et al. Orphan G protein‐coupled receptors: targets for new therapeutic interventions , 2004, Annals of medicine.
[36] S. Munro. Lipid Rafts Elusive or Illusive? , 2003, Cell.
[37] M. Edidin,et al. Shrinking patches and slippery rafts: scales of domains in the plasma membrane. , 2001, Trends in cell biology.
[38] E. Ikonen,et al. How cells handle cholesterol. , 2000, Science.
[39] G. Gimpl,et al. Regulation of receptor function by cholesterol , 2000, Cellular and Molecular Life Sciences CMLS.
[40] D. M. Amundson,et al. Fluorometric method for the enzymatic determination of cholesterol. , 1999, Journal of biochemical and biophysical methods.
[41] D. Pimentel,et al. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. , 1998, Circulation.
[42] Richard G. W. Anderson,et al. Lipid rafts: at a crossroad between cell biology and physics , 2007, Nature Cell Biology.
[43] G. Gimpl,et al. Cholesterol and steroid hormones: modulators of oxytocin receptor function. , 2002, Progress in brain research.
[44] J. Slotte,et al. Cholesterol interactions with phospholipids in membranes. , 2002, Progress in lipid research.